Imdevimab - Research Grade Biosimilar

• NCBI Gene ID :

  43740568

• Swiss Prot :

  P0DTC2

• Accession Number :

  P0DTC2

• Immunogen :

  Homo sapiens / SARS-CoV-2 Spike RBD

• Clonality :

  Recombinant Monoclonal

• Conjugation :

  Unconjugated

• Type :

  Primary Antibodies, Biosimilars

• Source :

  CHO cells

• Field of Research :

  Other

• Purification :

  >95%

• Concentration :

  Batch dependent

• Purity :

  >95%

• Buffer :

  PBS buffer pH 7.5

• Modification :

  None

• Shipping Conditions :

  Blue Ice

• Storage Conditions :

  Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at +4°C short term (1-2 weeks) . Store at -20 °C 12 months. Store at -80°C long term.

• Fragment :

  IgG1, Lambda

• Symbol :

  S

• NCBI Official Name :

  Surface glycoprotein

• NCBI Organism :

  Severe acute respiratory syndrome coronavirus 2

• Other Product Names :

  IMDEVIMAB, IMDEVIMAB [INN], IMDEVIMAB [USAN], IMDEVIMAB [WHO-DD], IMMUNOGLOBULIN G1, ANTI- (SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 SPIKE GLYCOPROTEIN) (HUMAN MONOCLONAL REGN10987 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL REGN10987 .LAMBDA.-CHAIN, DIMER REGN10987, REGN-10987, , spike glycoprotein

• CAS Number :

  2415933-40-1